The Proteomics Shared Resource (PSR) is a specialized technical facility with the primary goal of protein identification, characterization and quantitation, and is open to all Cancer Center members at CSHL. The Proteomics Shared Resource is located within the W.M. Keck Structural Biology Laboratory on the ground floor ofthe Beckman building. In the last 18 months CSHL has completed a major restructuring ofthe Resource. A senior faculty member with significant expertise in proteomics was recruited to redesign and oversee the Shared Resource. In addition, a PhD-level scientist with experience in proteomics and mass spectrometry was recruited to manage and run the facility. With the new staff in place, state-of-the-art equipment was purchased and the laboratory space was extensively renovated. The Resource features new, state-of-the-art equipment, including: one Thermo LTQ-Orbitrap mass spectrometer, one Thermo LTQ iontrap mass spectrometer, one Agilent 6520 quadrupole time-of-flight (QTOF) mass spectrometer and one Thermo Vantage triple quadrupole mass spectrometer, all fitted with nano electrospray (NanoESl) sources. A second Orbitrap Velos mass spectrometer with ETD source (funded through the High-End Instrumentation program) is due to be installed in late 2010. An additional Accela HPLC and autosampler is also available for analytical scale MRM work using the Vantage triple-Quad.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA045508-27
Application #
8712160
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
27
Fiscal Year
2014
Total Cost
$344,981
Indirect Cost
$132,619
Name
Cold Spring Harbor Laboratory
Department
Type
DUNS #
065968786
City
Cold Spring Harbor
State
NY
Country
United States
Zip Code
11724
Tiriac, Hervé; Belleau, Pascal; Engle, Dannielle D et al. (2018) Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. Cancer Discov 8:1112-1129
Forcier, Talitha L; Ayaz, Andalus; Gill, Manraj S et al. (2018) Measuring cis-regulatory energetics in living cells using allelic manifolds. Elife 7:
Naguib, Adam; Mathew, Grinu; Reczek, Colleen R et al. (2018) Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells. Cell Rep 23:58-67
Aberle, M R; Burkhart, R A; Tiriac, H et al. (2018) Patient-derived organoid models help define personalized management of gastrointestinal cancer. Br J Surg 105:e48-e60
Bhagwat, Anand S; Lu, Bin; Vakoc, Christopher R (2018) Enhancer dysfunction in leukemia. Blood 131:1795-1804
Khan, Jalal A; Maki, Robert G; Ravi, Vinod (2018) Pathologic Angiogenesis of Malignant Vascular Sarcomas: Implications for Treatment. J Clin Oncol 36:194-201
Chen, Wei-Chia; Tareen, Ammar; Kinney, Justin B (2018) Density Estimation on Small Data Sets. Phys Rev Lett 121:160605
Cheng, Derek; Tuveson, David (2018) Kras in Organoids. Cold Spring Harb Perspect Med 8:
Albrengues, Jean; Shields, Mario A; Ng, David et al. (2018) Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science 361:
Cook, Natalie; Basu, Bristi; Smith, Donna-Michelle et al. (2018) A phase I trial of the ?-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma. Br J Cancer 118:793-801

Showing the most recent 10 out of 380 publications